Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other Accumulated Expenses (2017 - 2018)

Historic Other Accumulated Expenses for Cue Biopharma (CUE) over the last 2 years, with Q4 2018 value amounting to $79188.0.

  • Cue Biopharma's Other Accumulated Expenses fell 1907.78% to $79188.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $79188.0, marking a year-over-year decrease of 1907.78%. This contributed to the annual value of $79188.0 for FY2018, which is 1907.78% down from last year.
  • Latest data reveals that Cue Biopharma reported Other Accumulated Expenses of $79188.0 as of Q4 2018, which was down 1907.78% from $97857.0 recorded in Q4 2017.
  • Cue Biopharma's Other Accumulated Expenses' 5-year high stood at $97857.0 during Q4 2017, with a 5-year trough of $79188.0 in Q4 2018.